2017 The Japanese Society of Medical Oncology Annual Meeting

Call for Abstracts

Call for Abstracts has closed.
Notification of Acceptance/Rejection has been sent out to the applicants.
Please contact the secretariat (jsmo2017@congre.co.jp) if you have not received.

Abstract Submission Period

Abstract submission opening: Thursday, December 15, 2016

Abstract submission closing: Thursday, February 2, 2017 at noon JST
Thursday, February 9, 2017 at noon JST
Tuesday, February 14, 2017 at noon JST

Call for Abstracts

International Session / Symposium / Workshop

International Session(Open Call / Partially Invited)

Comprehensive Symptom Screening and Early Palliative care
—From the Start of Cancer Treatment—

Summary

Symposium(Open Call / Partially Invited)

Newest knowledge in gastric cancer

Summary

Workshop(Open Call / Partially Invited)

Current landscape and future perspectives of biomarker study in breast cancer

Summary

Free paper (Oral / Poster Presentation)

JSMO2017 is accepting abstracts for free paper.
Presentation style will be either Oral presentation or Poster presentation.

Please select the abstract category from the list below. (The 1st & 2nd choices are required.)

Abstract Category for Free Paper

1 -
2 Pediatric malignancy
3 Brain tumors
4 Head and neck cancer
5 Breast cancer
6 Esophageal cancer
7 Gastric cancer
8 Colorectal cancer
9 Hepatoma / HCC
10 Biliary tract cancer / Pancreatic cancer
11 Lung cancer
12 Uterin cancer / Ovarian cancer
13 Other gynecological cancer
14 Urologic cancer
15 Endocrine tumors / Thyroid cancer
16 Skin cancer
17 Bone and soft tissue tumors
18 Lymphoma
19 Leukemia
20 Other hematological malignancies
21 Cancer of unknown primary
22 Neuroendocrine tumors
23 Hereditary neoplasm
24 Therapeutic radiology
25 Basic research
26 Immunology
27 Cancer epigenetics
28 Translational research
29 Innovative drug research & development
30 Early clinical development
31 Clinical pharmacology
32 Biostatistics
33 Regulatory science
34 Clinical trial support
35 Molecular-targeted drug
36 Cytotoxic drug
37 Immunotherapy
38 Other anti-cancer drugs
39 Pharmaceutical science
40 Big data
41 Trials in progress (a)
42 Molecular and genetic diagnosis
43 Companion diagnostics
44 Diagnostic imaging
45 Other diagnostics
46 Supportive care
47 Palliative medicine
48 Regional medical network
49 Team medical care
50 Rehabilitation
51 Outpatient chemotherapy
52 -
53 -
54 Oncology nursing
55 Oral care
56 Patient advocacy / Cancer survivorship
57 Adolescent and Young Adult Oncology
58 Geriatric Oncology
59 Healthcare economics
60 Case reports
61 Others

(a) Please note that if you select, “Trials in Progress,” your abstract will NOT be included in the JSMO2017 USB abstract or any other available electronic program, such as “My schedule.” Your submitted abstracts will be printed and handed out to the participants at the room where you deliver your presentation.

* Abstract Encouragement Award

  • Age limitation: The first author must be under the age 40 (as of July 29, 2017)
  • Once you are nominated as a candidate, you will be requested to submit an electronic data for review in May, 2017.
  • If you would like to be reviewed as a candidate, please check the box to be reviewed as the candidate for the Abstract Encouragement Award.

* All submitted abstracts will be reviewed by the Peer Review Committee, and will be decided based on the study contents, ethical aspects, and etc. Please register the style of presentation (oral or poster). However, it will be the Chairman’s decision on the presentation style, presentation, session, as well as acceptance/rejection.

Late-breaking abstracts

JSMO2017 will be holding deep discussions based on leading-edge research result, and calls for “Late-breaking” abstracts.
If you are applying for Late-breaking abstracts, please select “Yes” for the question, “Are you applying for late-breaking abstracts?” and submit an outline and predicted result of your research as interim registration in the abstract text box.
Please complete the submission by Friday, April 14, 2017.(You will be notified by the Secretariat to complete the abstract submission at the beginning of April, 2017.)

* Your abstract may not be included in the JSMO2017 USB Abstract, if the complete abstract is submitted later than Friday, April 14. This is due to the USB Abstract must be prepared at a certain time before the congress.

Plenary Session (International Session)

JSMO2017 is planning to have “Plenary Sessions”.

* The topic of the plenary session will be selected from among the submitted titles.

Travel Award

Abstracts submitted by young researchers who live outside of Japan will be reviewed by the JSMO2017 Organizer. The presenters will receive partial travel grant for their outstanding work.

*JPY50,000-100,000 of travel support to investigators from Asia. (depending on the quality of abstract)
*JPY150,000 of travel support to investigators from US or EU.
*If you are receiving support from any company, your application for Travel Award will be not qualified to receive this award.

Publication in “Annals of Oncology”

Abstracts (oral/ poster) submitted in English for JSMO2017 Annual Meeting will be published in ESMO/JSMO Scientific Journal, supplement to “Annals of Oncology” (Oxford University Press).
If you wish to have your abstract published in “Annals of Oncology,” please select “Yes”.

* Terms to be published in Journal "Annals of Oncology" as to poster presentation:

(1)Your abstract must be accepted for poster presentation.
(2)To be published in the Journal “Annals of Oncology,” the posting fee (5,000JPY) must be paid in addition to the Congress registration fee.
(3)The payment must be made through the online pre-registration site (From the beginning of April, 2017 to June, 2017)

* How to Register:

(1)When you enter the pre-registration site, your poster presentation ID number and title will show up. If you wish to be published in the journal, “Annals of Oncology,” please check the applicable box(es).
(2)Please proceed with making your payment by credit card for both for the publishing and registration for the congress.

Disclosure of Conflict of Interest at the Japanese Society of Medical Oncology 2017 Annual Meeting

The first authors and directors (who are in charge of the studies, usually last author) must disclose applicable COI (Conflict of Interest) of your presentation at the meeting. Please inform the COI from January 1, 2016 to December 31, 2016.

COI Disclosure Information

COI policy

Detailed Enforcement regulations of COI

pdf
To view the PDF files, you may need, “Adobe Reader”
(Download Adobe Reader

For oral presentation, please use the following slide as a template to disclose conflict of interest.
For poster presentation, please prepare and print out the slide, and put it at lower right of the poster panel.

Template of slide

Questions regarding COI disclosure

The Secretariat of the Japan Society of Medical Oncology
E-mail: btn

Abstract Submission

Guideline

We accept abstracts submitted online only through the submission system.
You can go to the submission page from the button “Abstract Submission” located at the bottom of this page.

(1)Author information and abstracts must be submitted in English.
(2)Abstract title must be up to 120 single-byte characters.
(3)Abstract text must be up to 2,000 single-byte characters.
(4)The maximum of 10 authors (first author & co-authors) can be registered.
(5)The maximum of 10 affiliations (including the affiliation of the first author) can be registered.
(6)If possible, please structure your abstract with:
Background:
Methods:
Results:
Conclusion:
(7)Any chart or diagram cannot be included.
(8)Regarding the special characters, please refer here.
(9)In the registration page, you will be asked to enter the information such as “application for Late-breaking abstracts”, “application for Travel Award”, “Publication in Annals of Oncology” as well as, COI information.
*It is recommended that you prepare your abstract text by Word/ text file in advance, and then copy it on the registration page.
*After completing the abstract submission, the abstract registration ID number and your password will be sent to the first author’s email address. The ID number and password will be required to confirm/modify/delete/add abstracts. Please be sure to enter the correct e-mail address. Please be sure to keep the ID number and password by yourself. The congress secretariat does NOT keep track of your information.

Confirmation / Modification / Deletion of Submitted Abstract & Additional Submission

You can access to confirm/modify/delete/add abstracts during the abstract submission period. The ID number and password will be required to enter the page (confirm/modify/delete/add abstracts).

Acceptance/rejection notification

Notification of acceptance/rejection will be sent by email, by May, 2017, to the first author.

Abstract Submission

  • Abstract Submission

Confirmation / Modification / Deletion of submitted abstract & Additional submission Page

  • Confirmation / Modification / Deletion / Additional submission

Inquiries for Abstract Submission

Congress Secretariat
c/o Congress Corporation
3-6-13 Awajimachi, Chuo-ku, Osaka 541-0047, Japan
Phone: +81-6-6229-2555   Fax: +81-6-6229-2556
E-mail: jsmo2017@congre.co.jp

Secretary

Department of Hematology,
Oncology, and Respiratory Medicine
Okayama University Graduate
School of Medicine
2-5-1 Shikata-cho, Kita-ku, Okayama
700-8558, Japan

Congress Secretariat

c/o Congress Corporation
3-6-13 Awajimachi, Chuo-ku,
Osaka 541-0047, Japan
Phone: +81-6-6229-2555
Fax: +81-6-6229-2556
E-mail: jsmo2017@congre.co.jp